Komori
Yamashin-Filter Corp. (6240) · RiskWorsened

Delays in Establishing Mass-Production Capacity for Masks and Insufficient Reduction in Manufacturing Costs

First written in FY2021-Q3. 1 of 3 entries say "Restated". Latest entry: FY2022-Q2.

3entries
1years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021-Q3 – FY2022-Q12021: 32021
Same theme, other companies

0 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2022-Q2WorsenedAnnual report

    「However, during the second quarter of the current consolidated cumulative period, the manufacturing process was still under development, and insufficient reductions in manufacturing costs resulted in an operating loss.」

    The establishment of the mask manufacturing process remained incomplete and cost reductions remained insufficient, resulting in an operating loss of ¥236 million in the healthcare business. The company also recognized an impairment loss of ¥243 million on property, plant and equipment with low productivity and profitability.
  2. FY2022-Q1RestatedAnnual report

    「However, during the first quarter of the current consolidated cumulative period, the manufacturing process was still under development, and the healthcare business performed poorly because manufacturing costs could not be reduced sufficiently.」

    The company continued to report poor performance in the healthcare business due to the manufacturing process for masks still being under development and insufficient reductions in manufacturing costs.
  3. FY2021-Q3First statedAnnual report

    「Meanwhile, establishing our mask mass-production system took considerable time because it involved developing a manufacturing process using filter sheets made of nanofiber material with an unprecedented three-dimensional structure, substantially delaying supplies to drugstores and other markets. In addition, because manufacturing costs were not sufficiently reduced during the process of establishing mass-production capacity, the healthcare business performed extremely poorly in the third quarter of the current fiscal year.」

    The company stated that establishing a manufacturing process using nanofiber material with a three-dimensional structure took time, resulting in delays in supplies to drugstores and other outlets and insufficient reductions in manufacturing costs.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Yamashin-Filter Corp.'s next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.